IPPMed

IPPMed (Institute for Personalized and Predictive Medicine) is a biotechnology research organization dedicated to the study of aging and the development of longevity-extending therapies. The company leverages big data and physics-based modeling to identify biomarkers of biological age and discover potential drug candidates for age-related conditions. IPPMed is the foundational research entity behind the Gero platform, which focuses on drug repurposing and the identification of novel targets for chronic diseases. Their work aims to transform healthcare from a reactive model to a predictive and personalized approach focused on healthy lifespan extension. By integrating longitudinal biological data with advanced computational methods, IPPMed seeks to uncover the fundamental mechanisms of human aging.